ARID3A and familial pancreatic carcinoma: A recent study demonstrated that the knockout of the transcription factor AT-rich interactive domain-containing protein 3A (ARID3A) can inhibit tumor progression in pancreatic cancer and enhance the sensitivity of cells to gemcitabine.